“Your bone density shows osteoporosis. I think we should start medication.”

And the patient immediately thinks:

Do I really need it?

Then they go home and search the medication online.

Now they’re reading about jaw problems, unusual thigh fractures, stomach problems, injections, infusions and warnings they don’t completely understand.

Suddenly osteoporosis—which didn’t hurt and wasn’t bothering them yesterday—feels less frightening than the medication being offered to treat it.

I understand why patients hesitate.

But fear shouldn’t make the decision.

Understanding should.

Why Treat Something You Can’t Feel?

This is one of the hardest things about osteoporosis treatment.

If you have pneumonia, you want to breathe better.

If you have arthritis, you want less pain.

Osteoporosis medication doesn’t usually make you feel different.

Its purpose is to reduce your risk of a future fracture.

That can make treatment feel abstract.

You’re taking a medication today to prevent something that may—or may not—happen years from now.

But osteoporosis-related fractures are not minor events, particularly fractures of the hip and spine.

So the real conversation isn’t simply:

“Do I want to take a medication?”

It’s:

“What is my risk of fracture, and how much could this treatment reduce that risk?”

There Isn’t Just One Osteoporosis Medication

People often talk about “the osteoporosis drug” as though there were only one.

There are several types.

Bisphosphonates are among the most commonly prescribed. Medications such as alendronate, risedronate and zoledronic acid slow the process that breaks down bone.

Some are pills. Others can be given by IV infusion.

Denosumab is given by injection and also slows bone breakdown.

Other medications work differently. Some help stimulate new bone formation and may be considered for people at particularly high fracture risk.

There are also medications that affect estrogen pathways and may be appropriate for certain patients.

The important point is that treatment isn’t one-size-fits-all.

Your fracture risk, age, other medical conditions, kidney function, previous fractures and even your ability to take a medication correctly can influence the choice.

Then Come the Scary Stories

This is where patients understandably get nervous.

Bisphosphonates have been associated with rare complications including osteonecrosis of the jaw, in which jawbone tissue is damaged, and unusual fractures of the thigh bone known as atypical femur fractures.

Those are real complications.

They shouldn’t be dismissed.

But they are also uncommon when these medications are being used to treat osteoporosis.

This is where perspective matters.

A frightening side effect can sound enormous when you read about it by itself.

The question is not whether a medication has risk.

Every medication has risk.

The question is whether the risk of the medication is greater or smaller than the risk of leaving your osteoporosis untreated.

For someone with mild bone loss and low fracture risk, that calculation may look one way.

For someone who has already had a hip or spinal fracture, it may look very different.

“My Friend Had a Terrible Reaction”

Patients tell healthcare professionals things like this all the time.

And I listen.

Your friend’s experience matters to your friend.

Your previous medication reactions matter to you.

But another person’s experience doesn’t automatically predict yours.

Instead of dismissing the story—or allowing it to make the decision for you—bring the concern into the conversation.

“I’ve heard this medication can cause jaw problems. How common is that for someone like me?”

That’s a good question.

So is:

“What happens if I don’t take it?”

Patients deserve both sides of that answer.

How You Take the Medication Can Matter

Some oral bisphosphonates have very specific instructions.

You may need to take the pill first thing in the morning with plain water, before eating or taking other medications, and remain upright for a period afterward.

Those instructions aren’t busywork.

They’re designed partly to help the medication absorb properly and reduce irritation of the esophagus.

If that routine isn’t realistic for you—or you have certain gastrointestinal problems—tell your healthcare provider.

There may be another option.

The best medication on paper isn’t particularly helpful if you cannot safely or realistically take it.

Don’t Just Stop Some Osteoporosis Medications

This is particularly important with denosumab.

It should not simply be stopped or delayed indefinitely without a plan because bone loss can accelerate after discontinuation and the risk of vertebral fractures can increase.

Other osteoporosis medications may be intentionally paused after several years in selected patients.

You may hear the term “drug holiday.”

That does not mean everyone should stop osteoporosis medication after a certain number of years.

It means treatment needs to be reassessed.

What you started five years ago doesn’t automatically have to continue unchanged forever.

Ask Better Questions

If medication is recommended, you don’t have to say yes before you understand it.

And you don’t have to say no because something you read frightened you.

Ask:

Why are you recommending medication for me?

How high is my fracture risk?

What benefit should I expect?

What are the common side effects?

What are the serious but uncommon risks?

Are there alternatives?

How long will I likely take it?

How will we know whether it’s working?

Those are reasonable patient questions.

This Isn’t About Being “Good” and Taking Your Medicine

Patients sometimes feel as though refusing a medication makes them difficult.

It doesn’t.

And agreeing to treatment without understanding it doesn’t make you a better patient.

This is your body.

You deserve enough information to make an informed decision.

Osteoporosis medications can significantly reduce fracture risk for people who need them. They also have potential side effects and considerations that deserve a real conversation.

Both things can be true.

The goal isn’t to frighten you into treatment.

And it isn’t to frighten you away from it.

The goal is to understand your risk, understand your options and make the decision that makes sense for you.

References

National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis: Diagnosis, Treatment, and Steps to Take.

U.S. Food and Drug Administration. Bisphosphonate Drug Safety Information.

Bone Health & Osteoporosis Foundation. Osteoporosis Medication and Medication Guidelines.

Endocrine Society. Pharmacological Management of Osteoporosis in Postmenopausal Women.